NewsAvi Kapoor
Sunshine Biopharma
SBFM · NASDAQ
$0.22−$0.0218 (−9.02%)TodayMarket closed ·
Prev close $0.2418
Latest news
- NewsAvi Kapoor
Dow Falls Over 100 Points; US Initial Jobless Claims Decline
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsAvi Kapoor
US Stocks Mixed; Nasdaq Gains Over 50 Points
- Press releaseACCESS Newswire
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
- NewsVandana Singh
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
- Press releaseGlobe Newswire
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
- NewsVandana Singh
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
- Press releaseACCESS Newswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
- NewsVandana Singh
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
- Press releaseACCESS Newswire
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
- NewsVandana Singh
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
- News
EXCLUSIVE: Sunshine Biopharma Gets Canadian Regulatory Approval Of Generic Dienogest Tablets
- Press releaseACCESS Newswire
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
- Press releaseACCESS Newswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
- NewsAvi Kapoor
Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
- NewsTanya Rawat
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today
- NewsAvi Kapoor
Dow Jumps Around 200 Points; Best Buy Posts Upbeat Q1 Results
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsDylan Berman
Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseACCESS Newswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- NewsAvi Kapoor
Nasdaq Down 200 Points; Brady Earnings Top Views
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
- Press releaseGlobe Newswire
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
- Press releaseACCESSWIRE
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.